Vivo Capital VIII, LLC Transaction History

Date Transaction Value Shares Traded Form
Nov 21 2023
SELL
Open market or private sale
$3,060 $0.9 p/Share
3,400
Nov 20 2023
SELL
Open market or private sale
$50,324 $0.92 p/Share
54,700
Nov 17 2023
SELL
Open market or private sale
$7,572 $0.93 p/Share
8,143
Nov 17 2023
SELL
Open market or private sale
$7,636 $0.93 p/Share
8,211
Nov 16 2023
SELL
Open market or private sale
$14,400 $0.96 p/Share
15,000
Feb 09 2021
SELL
Open market or private sale
$4,520 $20.0 p/Share
226
Feb 09 2021
BUY
Conversion of derivative security
-
3,414,343
Feb 09 2021
BUY
Exercise of in-the-money or at-the-money derivatives securities
$4,502 $0.07 p/Share
64,319
Feb 09 2021
BUY
Open market or private purchase
$7,000,000 $20.0 p/Share
350,000

Also insider at

CRNX
Crinetics Pharmaceuticals, Inc. Healthcare
IMPL
IMPEL PHARMACEUTICALS INC Healthcare
TERN
Terns Pharmaceuticals, Inc. Healthcare
ALGS
Aligos Therapeutics, Inc. Healthcare
VCV

Vivo Capital Viii, LLC

> 10% Shareholder
Palo Alto,, CA

Track Institutional and Insider Activities on BOLT

Follow Bolt Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BOLT shares.

Notify only if

Insider Trading

Get notified when an Bolt Biotherapeutics, Inc. insider buys or sells BOLT shares.

Notify only if

News

Receive news related to Bolt Biotherapeutics, Inc.

Track Activities on BOLT